NCAM1 and small cell lung carcinoma: A recent immunofluorescence study on a large cohort of 108 SCLC patients demonstrate that EpCAM-based methodology (Cellsearch®) was unable to detect CD56+ and/or TTF1+-CTC in more than 20% of patients14.